These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6676761)

  • 1. [Specific responses to drug therapy and Leonhard classification of chronic schizophrenia].
    Ban TA; Kelwala S; Wilson WH
    Seishin Shinkeigaku Zasshi; 1983; 85(9):598-600. PubMed ID: 6676761
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of diagnostic criteria on the prevalence of schizophrenic subtypes.
    Stompe T; Ortwein-Swoboda G; Ritter K; Marquart B; Schanda H
    Compr Psychiatry; 2005; 46(6):433-9. PubMed ID: 16275210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peculiarities and difficulties in the systematic drug therapy of chronic schizophrenics (schizophrenic "defect")].
    Lange E; König L; Eymann B
    Psychiatr Neurol Med Psychol (Leipz); 1981 Jan; 33(1):34-8. PubMed ID: 7220687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schizophrenia: unity in diversity].
    van den Bosch RJ
    Ned Tijdschr Geneeskd; 1993 May; 137(21):1039-43. PubMed ID: 8505999
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Associated psychotropic drugs in deficit schizophrenia].
    Beaufils B
    Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysthymic schizophrenia. An investigation of its evolution].
    Béguin T
    Encephale; 1994; 20(4):385-92. PubMed ID: 7988402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The course and outcome of chronic schizophrenia (author's transl)].
    Yuan GQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Feb; 13(2):105-6. PubMed ID: 7428547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia.
    Basso MR; Nasrallah HA; Olson SC; Bornstein RA
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):107-12. PubMed ID: 9150511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do anticonvulsants hinder clozapine treatment?
    Wilson WH
    Biol Psychiatry; 1995 Jan; 37(2):132-3. PubMed ID: 7718678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment refractory schizophrenia].
    Vanelle JM
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
    [No Abstract]   [Full Text] [Related]  

  • 16. [Classification of non-paranoid type schizophrenia--discussion on a psychopathological view of linguistic differences and relationship].
    Hane A; Nishioka K; Koide H
    Seishin Shinkeigaku Zasshi; 1991; 93(10):933-50. PubMed ID: 1801030
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 18. An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.
    Nakajima S; Uchida H; Suzuki T; Tomita M; Tsunoda K; Kitta M; Takeuchi H; Nomura K; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2007 Aug; 27(4):401-3. PubMed ID: 17632230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Schizophrenic defect syndrome--a clinical evaluation].
    Jucha Z; Rzecki Z
    Psychiatr Pol; 1975; 09(2):129-36. PubMed ID: 1135335
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.